BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17413999)

  • 21. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nicardipine pellets for the prevention of cerebral vasospasm.
    Thomé C; Seiz M; Schubert GA; Barth M; Vajkoczy P; Kasuya H; Schmiedek P
    Acta Neurochir Suppl; 2011; 110(Pt 2):209-11. PubMed ID: 21125473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose intra-arterial nicardipine results in hypotension following vasospasm treatment in subarachnoid hemorrhage.
    Rosenberg N; Lazzaro MA; Lopes DK; Prabhakaran S
    Neurocrit Care; 2011 Dec; 15(3):400-4. PubMed ID: 21468780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simplified method for administration of intra-arterial nicardipine for vasospasm with cervical catheter infusion.
    Pandey P; Steinberg GK; Dodd R; Do HM; Marks MP
    Neurosurgery; 2012 Sep; 71(1 Suppl Operative):77-85. PubMed ID: 22105209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-arterial verapamil-induced seizures: case report and review of the literature.
    Westhout FD; Nwagwu CI
    Surg Neurol; 2007 May; 67(5):483-6; discussion 486. PubMed ID: 17445610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Endovascular treatment of vasospasm following subarachnoid aneurysmal haemorrhage].
    Abdennour L; Lejean L; Bonneville F; Boch AL; Puybasset L
    Ann Fr Anesth Reanim; 2007 Nov; 26(11):985-9. PubMed ID: 17935940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The challenge of blood pressure management in neurologic emergencies.
    Talbert RL
    Pharmacotherapy; 2006 Aug; 26(8 Pt 2):123S-130S. PubMed ID: 16863478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Two patients treated with intra-aortic balloon pump counterpulsation after subarachnoid hemorrhage].
    Sato K; Tokairin H; Kato M
    Masui; 2001 Aug; 50(8):859-62. PubMed ID: 11554017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraventricular nicardipine for refractory cerebral vasospasm after subarachnoid hemorrhage.
    Goodson K; Lapointe M; Monroe T; Chalela JA
    Neurocrit Care; 2008; 8(2):247-52. PubMed ID: 17968520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of the FloTrac arterial pressure-based continuous cardiac output monitor to dobutamine-induced hyperdynamic therapy for cerebral vasospasm after subarachnoid hemorrhage].
    Mutoh T; Ishikawa T; Yasui N
    No Shinkei Geka; 2009 Nov; 37(11):1085-93. PubMed ID: 19938664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm.
    Badjatia N; Topcuoglu MA; Pryor JC; Rabinov JD; Ogilvy CS; Carter BS; Rordorf GA
    AJNR Am J Neuroradiol; 2004 May; 25(5):819-26. PubMed ID: 15140728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of an intravenous injection of nicardipine on cerebral blood flow in subarachnoid hemorrhage caused by intracranial aneurysm].
    Montarry M; Chacornac R; Philippon B; Bouchet C; Guichard P
    Agressologie; 1989 Jun; 30(7):411-5. PubMed ID: 2817238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraventricular nicardipine for aneurysmal subarachnoid hemorrhage related vasospasm: assessment of 90 days outcome.
    Lu N; Jackson D; Luke S; Festic E; Hanel RA; Freeman WD
    Neurocrit Care; 2012 Jun; 16(3):368-75. PubMed ID: 22160865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral vasospasm.
    Weir B; MacDonald L
    Clin Neurosurg; 1993; 40():40-55. PubMed ID: 8111992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium channel blockers and stroke.
    Inzitari D; Poggesi A
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):16-30. PubMed ID: 16640170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of nicardipine on cerebrospinal fluid pressure in humans.
    Nishikawa T; Omote K; Namiki A; Takahashi T
    Anesth Analg; 1986 May; 65(5):507-10. PubMed ID: 3083718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic manipulation in the neuro-intensive care unit: cerebral perfusion pressure therapy in head injury and hemodynamic augmentation for cerebral vasospasm.
    Diringer MN; Axelrod Y
    Curr Opin Crit Care; 2007 Apr; 13(2):156-62. PubMed ID: 17327736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical care guidelines on the endovascular management of cerebral vasospasm.
    Kimball MM; Velat GJ; Hoh BL;
    Neurocrit Care; 2011 Sep; 15(2):336-41. PubMed ID: 21761272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic approaches to vasospasm in subarachnoid hemorrhage.
    Dorsch NW
    Curr Opin Crit Care; 2002 Apr; 8(2):128-33. PubMed ID: 12386513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of nicardipine versus esmolol in attenuating the hemodynamic responses to anesthesia emergence and extubation.
    Kovac AL; Masiongale A
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):45-50. PubMed ID: 17289479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.